| SCC | Squamous cell carcinoma |
| BCC | Basal cell carcinoma |
| cSCC | Cutaneous squamous cell carcinoma |
| CPR | Complete pathological response |
| MPR | Major pathological response |
| PPR | Partial pathological response |
| NR | No pathological response |
| ORR | Objective response rate |
| TRAEs | Treatment-related adverse effects |
| DSS | Disease-specific survival |
| DFS | Disease-free survival |
| EFS | Event-free survival |
| QoL | Quality of life |
| ICIs | Immune checkpoint inhibitors |
| SOT | Solid organ transplants |
| NAIT | Neoadjuvant immunotherapy treatment |